Alex Shootman - 21 Feb 2025 Form 4 Insider Report for ALKAMI TECHNOLOGY, INC. (ALKT)

Role
Chief Executive Officer, Director
Signature
/s/ Douglas A. Linebarger, as Attorney-in-Fact for Alex Shootman
Issuer symbol
ALKT
Transactions as of
21 Feb 2025
Net transactions value
-$2,230,131
Form type
4
Filing time
26 Feb 2025, 19:56:35 UTC
Previous filing
11 Dec 2024
Next filing
11 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALKT Common Stock Award $0 +199,829 +21% $0.000000 1,141,893 21 Feb 2025 Direct F1
transaction ALKT Common Stock Sale $2,121,611 -71,421 -6.3% $29.71 1,070,472 26 Feb 2025 Direct F2, F3
transaction ALKT Common Stock Sale $108,520 -3,579 -0.33% $30.32 1,066,893 26 Feb 2025 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents time-based vesting of restricted stock units ("RSUs") that vest 1/16 each quarter for 4 years. Vesting commencement date is March 8, 2025.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transaction of prices ranging from $29.70 to $30.26. The Reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2024.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transaction of prices ranging from $30.27 to $30.44. The Reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.